SCHEDULE: Precigen Insider Sells $15.5M in Shares

Randal J. Kirk and affiliated entities sold over 4.7 million shares of Precigen, Inc. common stock for approximately $15.5 million.

Summary

• Randal J. Kirk, R.J. Kirk Declaration of Trust, and Third Security, LLC (Reporting Persons) filed Amendment No. 22 to their Schedule 13D.
• The amendment discloses the sale of 4,772,781 shares of Precigen, Inc. Common Stock by entities under Mr. Kirk's common control.
• The sales occurred in open market transactions on March 30, 2026, for aggregate net proceeds of approximately $15,581,221.
• Mr. Kirk's beneficial ownership is 133,956,416 shares, representing 35.9% of the class, including 988,659 exercisable options and 16,666,667 exercisable warrants.
• R.J. Kirk Declaration of Trust beneficially owns 97,339,485 shares, representing 26.1%, including 16,666,667 exercisable warrants.
• Third Security, LLC beneficially owns 21,843,458 shares, representing 5.9%.
• The percentage ownership is calculated based on 353,928,672 shares outstanding as of February 15, 2026, adjusted for recent equity compensation and exercisable options/warrants.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a moderately negative development due to the significant insider selling by a key beneficial owner, which can erode investor confidence despite being a routine disclosure for liquidity or portfolio rebalancing.

Negatives

• Significant insider selling by Randal J. Kirk and affiliated entities, totaling 4,772,781 shares.
• The sale of over $15.5 million in shares by a major beneficial owner could be perceived negatively by the market, potentially signaling a lack of confidence or a need for liquidity from the selling parties.

Risks

• Potential negative market perception due to significant insider selling by a controlling shareholder.
• Reduced alignment of interests between the selling insider and other shareholders.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that significant insider selling, especially by a controlling shareholder like Randal J. Kirk, can often be interpreted by the market as a signal regarding the company's future prospects or the insider's personal liquidity needs. While not inherently negative, it warrants close monitoring, particularly in the biotechnology sector where investor confidence in long-term vision is crucial.

Related Party Transactions

• The sale of 4,772,781 shares of Common Stock by entities under the common control of Mr. Kirk (the 'Selling Entities') constitutes a related party transaction.

Stakeholder Impact

• Shareholders: May interpret the insider selling as a negative signal, potentially leading to downward pressure on the stock price.
• Management: Could face questions regarding the implications of the insider's sale.

Key Dates

Recommendation

While significant insider selling by a major beneficial owner like Randal J. Kirk is generally a negative signal, this filing is an amendment to a long-standing Schedule 13D, indicating ongoing adjustments to a large position rather than a sudden exit. Investors should monitor future filings and company performance, but a 'hold' recommendation is appropriate given the lack of new fundamental company information and the possibility of personal liquidity reasons for the sale.

Keywords

Precigen Inc., PRGN, Schedule 13D/A, Insider Selling, Randal J. Kirk, Share Sale, Beneficial Ownership, Equity Compensation, Warrants, Options